Saba Capital Management, L.P. - Aug 29, 2025 SCHEDULE 13D/A Report for abrdn Life Sciences Investors Common Shares, $0.01 par value (HQL)

Filing Manager
Saba Capital Management, L.P.
Reporting Manager
Saba Capital Management, L.P.
Security
abrdn Life Sciences Investors Common Shares, $0.01 par value
Symbol
HQL
Shares outstanding
28.9M shares
Disclosed Ownership
2.98M shares
Ownership
10.3%
Form type
SCHEDULE 13D/A
Date filed
9/3/2025, 04:58 PM
Date of event
Aug 29, 2025
Previous filing
Apr 1, 2025
Next filing
Sep 26, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Saba Capital Management, L.P. 10.33% 2.98M 0 2.98M /s/ Michael D'Angelo General Counsel 0001510281
Boaz R. Weinstein 10.33% 2.98M 0 2.98M /s/ Michael D'Angelo Authorized Signatory 0001608233
Saba Capital Management GP, LLC 10.33% 2.98M 0 2.98M /s/ Michael D'Angelo Attorney-in-fact*